Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation

Cited by (379)

Items 101–200 of 379

1. Nicotine receptor partial agonists for smoking cessation
   Cahill, Kate, Stead, Lindsay F, Lancaster, Tim · 2010 · Cochrane Database of Systematic Reviews
2. Smoking outcome by psychiatric history after behavioral and varenicline treatment
   Jennifer B. McClure, Gary E. Swan, Sheryl L. Catz, Lisa M. Jack, Harold S. Javitz, Tim A. McAfee, Mona Deprey, Julie Angerhofer Richards, Susan M. Zbikowski · 2010 · Journal of Substance Abuse Treatment
3. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings
   Lara A. Ray, Kelly Elizabeth Courtney, Dara G. Ghahremani, Karen A. Miotto, Arthur L. Brody, Edythe D. London · 2014 · Psychopharmacology
4. Combination Therapies for Smoking Cessation
   Windle, Sarah B., Filion, Kristian B., Mancini, Joseph G., Adye-White, Lauren, Joseph, Lawrence, Gore, Genevieve C., Habib, Bettina, Grad, Roland, Pilote, Louise, Eisenberg, Mark J. · 2016 · American Journal of Preventive Medicine
5. Tabakentwöhnung bei COPD
   Stefan Andreas, Anil Batra, Jürgen Behr, Jean‐François Chenot, Adrian Gillissen, Thomas Hering, Felix J.F. Herth, Michael Kreuter, Rüdiger Meierjürgen, Stephan Mühlig et al. · 2014 · Pneumologie
6. Varenicline in smokers with diabetes: a pooled analysis of 15 randomized, placebo-controlled studies of varenicline
   Tonstad, Serena, Lawrence, David · 2017 · Journal of Diabetes Investigation
7. Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats
   Xiu Liu, Matthew Ian Palmatier, Anthony R. Caggiula, Alan F. Sved, Eric C. Donny, Maysa A. Gharib, Sheri Booth · 2008 · Psychopharmacology
8. Safety of Varenicline Among Smokers Enrolled in the Lung HIV Study
   Amy K. Ferketich, P. Diaz, Kristine K. Browning, B. Lu, Susan L. Koletar, Nancy R. Reynolds, Mary Ellen Wewers · 2012 · Nicotine & Tobacco Research
9. Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines
   Victor I. Reus, B. J. Smith · 2008 · International Journal of Clinical Practice
10. Cardiovascular Safety of Varenicline
    James H. Ware, George Wayne Vetrovec, Alan Bruce Miller, Andrew Van Tosh, Michael Gaffney, Carla Yunis, Carmen Arteaga, JEFFREY S. BORER · 2013 · American Journal of Therapeutics
11. Pharmacotherapy for smoking cessation: present and future
    Aubin, Henri-Jean, Karila, Laurent, Reynaud, Michel · 2011 · Current Pharmaceutical Design
12. GENETIC STUDY: Association between dopamine transporter genotypes and smoking cessation: a meta‐analysis
    John Stapleton, Gay Sutherland, Colin OʼGara · 2007 · Addiction Biology
13. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
    Ewoud Schuit, Orestis A. Panagiotou, Marcus Robert Munafo, Derrick Bennett, Andrew W. Bergen, Sean P. David · 2017 · Cochrane Database of Systematic Reviews · Retracted
14. Primary Care of the Patient with Chronic Obstructive Pulmonary Disease—Part 1: Frontline Prevention and Early Diagnosis
    Alan M. Radin, Claudia Côté · 2008 · The American Journal of Medicine
15. Hypomania with Agitation Associated with Varenicline Use in Bipolar II Disorder
    Anne E Morstad, Eric C Kutscher, William Klugh Kennedy, Ryan M. Carnahan · 2008 · Annals of Pharmacotherapy
16. A Tobacco Reconceptualization in Psychiatry: Toward the Development of Tobacco‐Free Psychiatric Facilities
    Taryn G. Moss, Andrea H. Weinberger, Jennifer C. Vessicchio, Vincenza Mancuso, Sandra J. Cushing, Michael Pett, Kate Kitchen, Peter L. Selby, Tony Peter George · 2010 · American Journal on Addictions
17. Recommendations for the Use of Pharmacological Smoking Cessation Strategies in Pregnant Women
    Tim J Coleman · 2007 · CNS Drugs
18. Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence
    Jon O. Ebbert, Michael V. Burke, James Taylor Hays · 2016 · Patient Preference and Adherence
19. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice
    Deniz Bağdaş, Yasmin Alkhlaif, Asti B. Jackson, Frank Ivy Carroll, Joseph W. Ditre, Mohamad Imad Damaj · 2018 · Neuropharmacology
20. Varenicline: A Selective α4β2 Nicotinic Acetylcholine Receptor Partial Agonist Approved for Smoking Cessation
    Sum Lam, Priti N. Patel · 2007 · Cardiology in Review
21. Human Abuse Liability of the Smoking Cessation Drug Varenicline in Smokers and Nonsmokers
    Shelley L. McColl, AH Burstein, K. R. Reeves, CB Billing, Marilyn J. Stolar, Edward M. Sellers · 2008 · Clinical Pharmacology & Therapeutics
22. Promoting smoking cessation
    Michele Larzelere, Dave E. Williams · 2005 · BDJ
23. Strategies for Quantifying the Relationship between Medications and Suicidal Behaviour
    Robert David Gibbons, J. John Mann · 2011 · Drug Safety
24. Tobacco smoking cessation management: integrating varenicline in current practice
    Laurence M Galanti · 2008 · Vascular Health and Risk Management
25. Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse
    Candice E. Van Skike, Sarah E. Maggio, Anna R. Reynolds, Erin M. Casey, Michael Thomas Bardo, Linda P. Dwoskin, Mark Prendergast, Kimberly Nixon · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
26. Abstinence and relapse among smokers who use varenicline in a quit attempt—a pooled analysis of randomized controlled trials
    Shade Agboola, Tim J Coleman, Ann D. McNeill, Jo Leonardi‐Bee · 2015 · Addiction
27. An open-label pilot trial ofN-acetylcysteine and varenicline in adult cigarette smokers
    Erin A. McClure, Nathaniel L. Baker, Cassandra D. Gipson, Matthew J. Carpenter, Amanda P. Roper, Brett Froeliger, Peter W. Kalivas, Kevin Michael Gray · 2014 · The American Journal of Drug and Alcohol Abuse
28. Smoking Cessation Interventions in Clinical Practice
    Jacques Cornuz · 2007 · European Journal of Vascular and Endovascular Surgery
29. Effects of Short-Term Varenicline Administration on Emotional and Cognitive Processing in Healthy, Non-Smoking Adults: A Randomized, Double-Blind, Study
    Roel J. T. Mocking, Chris Patrick Pflanz, Abbie Pringle, Elizabeth Parsons, Sarah F. B. McTavish, Philip J. Cowen, Catherine J. Harmer · 2012 · Neuropsychopharmacology
30. Varenicline
    Gillian M. Keating, Katherine Ann Lyseng-Williamson · 2010 · PharmacoEconomics
31. Varenicline: New treatment with efficacy in smoking cessation
    Victor I. Reus, Ronald Scott Obach, Jotham W. Coe, Hélène M. Faessel, Hans Rollema, Eric J. Watsky, Karen R. Reeves · 2007 · Drugs of today
32. Safety and Effectiveness of Varenicline in a Veteran Population with a High Prevalence of Mental Illness
    Tara L. Purvis, Scott Mambourg, Tracie M Balvanz, Heather E Magallon, Richard Pham · 2009 · Annals of Pharmacotherapy
33. Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions
    Dympna Harmey, Patrick R. Griffin, Paul J. Kenny · 2012 · Nicotine & Tobacco Research
34. Treating smoking dependence in depressed alcoholics.
    Nassima Ait‐Daoud, Wendy J. Lynch, Jennifer Kim Penberthy, Alison B. Breland, Gabrielle Marzani-Nissen, Bankole A. Johnson · 2006 · PubMed Central
35. Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers
    Daniel J. O. Roche, Lara A. Ray, Megan M. Yardley, Andrea C. King · 2016 · Current Addiction Reports
36. Reward Anticipation Is Differentially Modulated by Varenicline and Nicotine in Smokers
    John R. Fedota, Matthew T. Sutherland, Betty Jo Salmeron, Thomas J. Ross, Liyi Elliot Hong, Elliot A. Stein · 2015 · Neuropsychopharmacology
37. Varenicline for smoking cessation: A review of the literature
    Kirandeep Kaur, Sandeep Kaushal, Sarvesh Chander Chopra · 2009 · Current Therapeutic Research
38. A Longer Course of Varenicline Therapy Improves Smoking Cessation Rates
    Lee, John H., Jones, Philip G., Bybee, Kevin, O’Keefe, James H. · 2008 · Preventive Cardiology
39. Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings
    Lara A. Ray, Kelly Elizabeth Courtney, Dara G. Ghahremani, Karen A. Miotto, Arthur L. Brody, Edythe D. London · 2014 · The American Journal of Drug and Alcohol Abuse
40. Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement model
    Charles L. Pickens, Carlo Cifani, Brittany M. Navarre, Hila Eichenbaum, Florence R. M. Theberge, Michael H. Baumann, Donna J. Calu, Yavin Shaham · 2011 · Psychopharmacology
41. The effects of varenicline on attention and inhibitory control among treatment-seeking smokers
    Jessica D. Rhodes, Larry W. Hawk, Rebecca L. Ashare, Nicolas J. Schlienz, Martin Christopher Mahoney · 2012 · Psychopharmacology
42. Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries
    Karl Olov Fagerström, Masakazu Nakamura, Hong‐Jun Cho, Shih-Tzu Tsai, Chen Wang, Simon Davies, Wendy Ma, Theodore C. Lee, Cristina Russ · 2010 · Current Medical Research and Opinion
43. Sistema colinérgico: revisitando receptores, regulação e a relação com a doença de Alzheimer, esquizofrenia, epilepsia e tabagismo
    Ana Lúcia Marques Ventura, Paula Alvarez Abreu, Rodrigo Cesar Carvalho Freitas, P.C Sathler, Natália Loureiro, Helena Carla Castro · 2010 · Archives of Clinical Psychiatry (São Paulo)
44. Targeting nicotine addiction: the possibility of a therapeutic vaccine
    José Juan Escobar‐Chávez · 2011 · Drug Design Development and Therapy
45. Disrupting Nicotine Reinforcement
    Jed E. Rose · 2008 · Annals of the New York Academy of Sciences
46. Smoking Cessation Pharmacotherapy—Nicotine and Non‐Nicotine Preparations
    William H. Frishman · 2007 · Preventive Cardiology
47. Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans
    Mehmet Sofuoglu, Aryeh I. Herman, Marc E. Mooney, Andrew J. Waters · 2009 · Psychopharmacology
48. The effect of Varenicline on smoking cessation in a group of young asthma patients
    Christian Grabow Westergaard, Celeste Michala Porsbjerg, Vibeke Backer · 2015 · Respiratory Medicine
49. Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation
    Piotr Tutka · 2008 · Expert Opinion on Investigational Drugs
50. Smoking cessation-recent advances
    McNeil, John J., Piccenna, Loretta, Ioannides-Demos, Lisa L. · 2010 · Cardiovascular Drugs and Therapy
51. Evaluation of the cardiovascular effects of varenicline in rats
    Engin Burak Selçuk, Meltem Süngü, Hakan Parlakpınar, Necip Ermiş, Elif Taşlıdere, Nigar Vardı, Murat Yalçınsoy, Mustafa Sağır, Alaadin Polat, Mehmet Karataş et al. · 2015 · Drug Design Development and Therapy
52. High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial
    Kevin Michael Gray, Mark L. Rubinstein, Judith J. Prochaska, Sarah Dubrava, Ann R Holstein, Larry Samuels, Thomas D. McRae · 2020 · The Lancet Child & Adolescent Health
53. A review of the literature concerning HIV and cigarette smoking: Morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts
    Lauren R. Pacek, Rosa M. Crum · 2014 · Addiction Research & Theory
54. Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis
    Lawrence K Leung, Francis Patafio, Walter Rosser · 2011 · BMC Clinical Pharmacology
55. Cardiovascular Events in Patients taking Varenicline
    Mira Harrison‐Woolrych, Simran D. S. Maggo, Ming Tan, Ruth L Savage, Janelle Ashton · 2011 · Drug Safety
56. Update on pharmacologic and nonpharmacologic therapies for smoking cessation.
    Jason Schmelzle, Walter Rosser, Richard Birtwhistle · 2008 · Europe PMC (PubMed Central)
57. Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation
    Mandana Mahmoudi, Craig Ian Coleman, Diana M Sobieraj · 2012 · International Journal of Clinical Practice
58. Smoking Cessation: An Overview of Treatment Options with a Focus on Varenicline
    Nicole M. Stack · 2007 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
59. Varenicline for Smoking Cessation in Light Smokers
    Jon O. Ebbert, Ivana T. Croghan, Ryan T. Hurt, Darrell R. Schroeder, James Taylor Hays · 2016 · Nicotine & Tobacco Research
60. Effectiveness of varenicline for smoking cessation: A 1-year follow-up study
    M Grassi, Domenico Enea, Amy K. Ferketich, Bo Lü, Stefania Pasquariello, Paolo Nencini · 2011 · Journal of Substance Abuse Treatment
61. Smoking cessation therapy with varenicline
    Ganesh Krishna · 2008 · International Journal of COPD
62. The effects of varenicline on stress-induced and cue-induced craving for cigarettes
    Ray, Lara A., Lunny, Katy, Bujarski, Spencer, Moallem, Nathasha, Krull, Jennifer L., Miotto, Karen · 2013 · Drug and Alcohol Dependence
63. Pathological Video Gaming and Its Relationship to Substance Use Disorders
    Kenneth L. Smith, Tom A. Hummer, Leslie A. Hulvershorn · 2015 · Current Addiction Reports
64. Worsening Psychosis Induced by Varenicline in a Hospitalized Psychiatric Patient
    Bethany A. DiPaula, Michele Thomas · 2009 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
65. Organic Cation Transporter Variation and Response to Smoking Cessation Therapies
    Andrew W. Bergen, Harold S. Javitz, Ruth E. Krasnow, M. Michel, Denise Nishita, David V. Conti, Christopher K. Edlund, Pui–Yan Kwok, Jennifer B. McClure, Richard B. Kim et al. · 2014 · Nicotine & Tobacco Research
66. Smoking cessation: lessons learned from clinical trial evidence
    Robert D. Reid, Bonnie Quinlan, Dana L. Riley, Andrew Pipe · 2007 · Current Opinion in Cardiology
67. Smoking Cessation
    Rennard, Stephen I., Daughton, David M. · 2014 · Clinics in Chest Medicine
68. The Routledge Handbook of Destination Marketing
    Vanessa Gaitree Gowreesunkar, Hugues Séraphin, Alastair M. Morrison · 2018 · Routledge eBooks
69. Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study
    Hedwig Boudrez, Christina Gratziou, Michael Messig, Michael Metcalfe · 2011 · Current Medical Research and Opinion
70. Impact of early nausea on varenicline adherence and smoking cessation
    Annie R. Peng, Walter Swardfager, Neal L. Benowitz, Jasjit S. Ahluwalia, Caryn E. Lerman, Nicole L. Nollen, Rachel Fynvola Tyndale · 2019 · Addiction
71. Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation
    Harold S. Javitz, Susan M. Zbikowski, Mona Deprey, Tim A. McAfee, Jennifer B. McClure, Julie Angerhofer Richards, Sheryl L. Catz, Lisa M. Jack, Gary E. Swan · 2010 · Translational Behavioral Medicine
72. Quantitative Assessment of Exposure–Response Relationships for the Efficacy and Tolerability of Varenicline for Smoking Cessation
    Patanjali Ravva, Marc R. Gastonguay, Jonathan L French, Thomas G. Tensfeldt, Hélène M. Faessel · 2010 · Clinical Pharmacology & Therapeutics
73. Smoking cessation pharmacotherapy
    William H. Frishman · 2009 · Therapeutic Advances in Cardiovascular Disease
74. Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism
    Yadira X. Pérez-Páramo, Philip J. Lazarus · 2020 · Expert Opinion on Drug Metabolism & Toxicology
75. Varenicline’s effects on acute smoking behavior and reward and their association with subsequent abstinence
    Kenneth A. Perkins, Melissa Mercincavage, Carolyn A. Fonte, Caryn E. Lerman · 2010 · Psychopharmacology
76. Preclinical pharmacology, efficacy, and safety of varenicline in smoking cessation and clinical utility in high risk patients
    Zheng‐Xiong Xi · 2010 · Drug Healthcare and Patient Safety
77. Mental health stability in veterans with posttraumatic stress disorder receiving varenicline
    A. R. Campbell, K. D. Anderson · 2010 · American Journal of Health-System Pharmacy
78. Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice
    C. Wang, Byoung-Kyu Cho, Dan Xiao, Dalia Wajsbrot, P. W. Park · 2013 · International Journal of Clinical Practice
79. Varenicline for smoking cessation
    Serena Tonstad · 2007 · Expert Review of Neurotherapeutics
80. Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial
    Alexios Politis, Vasileios Ioannidis, Konstantinos I. Gourgoulianis, Zoe D. Daniil, Chrissi Hatzoglou · 2017 · Chronic Respiratory Disease
81. Indolizidine (−)-235B′ and related structural analogs: Discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine release
    Marharyta Pivavarchyk, Andrew Malvern Smith, Zhenfa Zhang, Dejun Zhou, Xu Wang, Naoki Toyooka, Hiroshi Tsuneki, Toshiyasu Sasaoka, J. Michael McIntosh, Peter Anthony Crooks et al. · 2011 · European Journal of Pharmacology
82. Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression
    Pejman Pirmoradi, Susan Roshan, Sofia S. Nadeem · 2008 · American Journal of Health-System Pharmacy
83. Efficacy and safety of varenicline for smoking cessation in schizophrenia: a meta-analysis.
    Ahmed, Saeed, Virani, Sanya, Kotapati, Vijaya P., Bachu, Ramya, Adnan, Mahwish, Khan, Ali M., Zubair, Aarij, Begum, Gulshan, Kumar, Jeevan, Qureshi, Mustafa et al. · 2018 · Frontiers in Psychiatry
84. Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study
    Mira Harrison‐Woolrych, Helen Paterson, Ming Tan · 2013 · Pharmacoepidemiology and Drug Safety
85. Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder
    Anne Eden Evins, Susanne S. Hoeppner, David Schoenfeld, Bettina B. Hoeppner, Corinne Cather, Gladys N. Pachas, Kristina M. Cieslak, Melissa Culhane Maravić · 2016 · Schizophrenia Research
86. New Weapon to Curb Smoking
    Bankole A. Johnson · 2006 · Archives of Internal Medicine
87. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers
    Daniel J.O. Roche, Spencer Bujarski, Emily E. Hartwell, ReJoyce Green, Lara A. Ray · 2015 · Pharmacology Biochemistry and Behavior
88. A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch
    Francesca E. Cunningham, Kwan Hur, Diane Dong, Donald R. Miller, Rongping Zhang, Xiangming Wei, Madeline McCarren, Andrew D. Mosholder, David J. Graham, Sherrie L. Aspinall et al. · 2016 · Addiction
89. Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers
    H. M. Faessel, Aaron H. Burstein, Matthew D. Troutman, Susan A. Willavize, Kevin D. Rohrbacher, D. J. Clark · 2008 · European Journal of Clinical Pharmacology
90. Cytisine Versus Varenicline for Smoking Cessation in a Primary Care Setting: A Randomized Non-inferiority Trial
    Tin Orešković, Sanja Percac‐Lima, Jeffrey M. Ashburner, Hrvoje Tiljak, Janez Rifel, Zalika Klemenc–Ketiš, Stjepan Orešković · 2023 · Nicotine & Tobacco Research
91. Varenicline use in patients with mental illness: an update of the evidence
    Tara L. Purvis, Leigh Anne Nelson, Scott Mambourg · 2010 · Expert Opinion on Drug Safety
92. Mouse model predicts effects of smoking and varenicline on event-related potentials in humans
    Noam D. Rudnick, Andrew A. Strasser, Jennifer M. Phillips, Christopher Jepson, Freda Patterson, Joseph M. Frey, Bruce I. Turetsky, Caryn E. Lerman, Steven J. Siegel · 2010 · Nicotine & Tobacco Research
93. Novel Pharmacological Approaches to Drug Abuse Treatment
    Ellen Lockard Edens, Alfredo A. Massa, Ismene L. Petrakis · 2009 · Current topics in behavioral neurosciences
94. Gabapentin for smoking cessation
    Amit Sood, Jon O. Ebbert, Kirk D. Wyatt, Ivana T. Croghan, Darrell R. Schroeder, Richa Sood, James Taylor Hays · 2010 · Nicotine & Tobacco Research
95. Evaluation of Cost-Utility of Varenicline Compared with Existing Smoking Cessation Therapies in South Korea
    Jung Youn Bae, Cheol Hwan Kim, Eui Kyung Lee · 2009 · Value in Health
96. Evidence for the Efficacy of a Bioresonance Method in Smoking Cessation: A Pilot Study
    Aylin Pıhtılı, Michael Galle, Çağlar Çuhadaroğlu, Zeki Kılıçaslan, Halim İşsever, Feyza Erkan, Tülin Çağatay, Ziya Gülbaran · 2014 · Complementary Medicine Research
97. Varenicline in smoking cessation
    Serena Tonstad, Hans Rollema · 2010 · Expert Review of Respiratory Medicine
98. Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages
    Mitsuhisa Koga, Yuki Kanaoka, Koshun Inada, Sai Omine, Yasufumi Kataoka, Atsushi Yamauchi · 2020 · Journal of Pharmacological Sciences
99. New Findings on Nicotine Addiction and Treatment
    Jed E. Rose · 2008 · Nebraska Symposium on Motivation/The Nebraska symposium on motivation
100. Visual hallucinations associated with varenicline: a case report
     B. Mahendri Raidoo, Eric C Kutscher · 2009 · Journal of Medical Case Reports